Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Placebo treatment can significantly influence subjective symptoms. However, it is widely believed that response to placebo requires concealment or deception. We tested whether open-label placebo (non-deceptive and non-concealed administration) is superior to a no-treatment control with matched patient-provider interactions in the treatment of irritable bowel syndrome (IBS). METHODS: Two-group, randomized, controlled three week trial (August 2009-April 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47 ± 18 with IBS diagnosed by Rome III criteria and with a score ≥ 150 on the IBS Symptom Severity Scale (IBS-SSS). Patients were randomized to either open-label placebo pills presented as "placebo pills made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes" or no-treatment controls with the same quality of interaction with providers. The primary outcome was IBS Global Improvement Scale (IBS-GIS). Secondary measures were IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR) and IBS Quality of Life (IBS-QoL). FINDINGS: Open-label placebo produced significantly higher mean (±SD) global improvement scores (IBS-GIS) at both 11-day midpoint (5.2 ± 1.0 vs. 4.0 ± 1.1, p<.001) and at 21-day endpoint (5.0 ± 1.5 vs. 3.9 ± 1.3, p = .002). Significant results were also observed at both time points for reduced symptom severity (IBS-SSS, p = .008 and p = .03) and adequate relief (IBS-AR, p = .02 and p = .03); and a trend favoring open-label placebo was observed for quality of life (IBS-QoL) at the 21-day endpoint (p = .08). CONCLUSION: Placebos administered without deception may be an effective treatment for IBS. Further research is warranted in IBS, and perhaps other conditions, to elucidate whether physicians can benefit patients using placebos consistent with informed consent. TRIAL REGISTRATION: ClinicalTrials.gov NCT01010191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The number-needed-to-treat was 11 which should be compared with 4 for ‘placebo without deception,259 7 for alosetron,260 8 for linaclotide261 and 14 for tegaserod.262”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [259]
The cited source says what the claim attributes to it.
In the citing paper
“Several trials of psychological treatments for IBS have failed to show differential effects on symptoms when using attention control conditions [32,62-64], and a recent study showed that IBS patients even respond to open-label placebo [65].”
The cited source says what the claim attributes to it.
In the citing paper
“Kaptchuk and colleagues showed that an open label inactive placebo pill produced better outcomes in IBS patients compared to no treatment13.”
From Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial (2014) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Collecting and Interpreting Qualitative Materials
Denzin, N. K., & Lincoln, Y. S. (2012) · Cited by 6,094
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“Participants were adults ($18 years old) meeting the Rome III criteria for IBS [17] with a score of $150 on the IBS Symptom Severity Scale (IBS-SSS).”
MethodFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 3×
“[18] The open-label group improved by 92 points on this measure; in addition, the improvement shown by the openlabel placebo group exceeded that shown by the no-treatment group by 46 points.”
MethodInfluentialIs the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“[7,8] It is a chronic functional gastrointestinal disorder characterized by abdominal pain and discomfort associated with altered bowel habits.”
BackgroundBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citation
Research works printed but not linked: 1
- Vanner SJ Depew WT Paterson WG 2004 Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome and functional dyspepsia. Gut 53 666 72 · DOI · Paper page
Cited by
Items 601–700 of 897
Estudillo‐Guerra, M. A., Mesia-Toledo, I., Schneider, J. C., & Morales-Quezada, L. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.697475 · Cited by 3
An Overview of Complementary and Alternative Medicine
Casarin, A., Tangkiatkumjai, M., & Walker, D. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-7039-4.ch001 · Cited by 2
Locher, C., & Koechlin, H. (2022) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2022.2121677 · Cited by 2
Miracle as Natural: A Contemporary Chinese American Religious Healer
Cheung, K. (2022) · Comparative philosophy of religion · doi:10.1007/978-3-031-14865-1_8 · Cited by 4
Krefting, F., Hölsken, S., Benson, S., Schedlowski, M., & Sondermann, W. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19258 · Cited by 3
Schienle, A., & Unger, I. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101175 · Cited by 2
“the body can learn to respond to placebos through conditioning, positive expectations/beliefs are helpful but not necessary, and that taking the placebo faithfully is crucial [30].”
BackgroundPsychopathologie et effet placebo en clinique de la douleur
Barfety-Servignat, V. (2023) · Douleur et Analgésie · doi:10.3166/dea-2022-0262 · Cited by 2
A worthwhile wager: the ethics of open-label placebo treatment in clinical practice
Hardman, D. I., & Miller, F. G. (2024) · Journal of Medical Ethics · doi:10.1136/jme-2024-110270 · Cited by 2
Self-citationDegen, B., Szczesna, A., Nickel, C. H., Bingisser, R. M., Gaab, J., & Minotti, B. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090508 · Cited by 2
Furie, K. S., James, K., Kaptchuk, T. J., & Diab, M. (2025) · Pain Management · doi:10.1080/17581869.2025.2520148 · Cited by 2
“…using OLP have demonstrated efficacy in treating a wide variety of symptoms including cancer-related fatigue [14], irritable bowel syndrome (IBS) [15,16], migraines [17], chronic osteoarthritis of the knee [18], allergic rhinitis [19,20], ischemic arm pain [21], caffeine withdrawal [22], and…”
Self-citationPlaceboeffekte in der Schmerztherapie
Klinger, R., Schwartz, M., & Bingel, U. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00942-9 · Cited by 3
Neurobiologische Grundlagen der Placebo-Analgesie
Eippert, F. (2020) · Der Schmerzpatient · doi:10.1055/a-1205-5280 · Cited by 2
“[42] Kaptchuk TJ, Friedlander E, Kelley JM et al.”
BackgroundThe Hedonic Procedural Effect of Traditional Medicines
Sato, A., & Costa‐Font, J. (2013) · Journal of Happiness Studies · doi:10.1007/s10902-013-9464-5 · Cited by 2
Static magnet therapy for pain relief: A critical review
Mundell, W. (2013) · OA Alternative Medicine · doi:10.13172/2052-7845-1-2-749 · Cited by 2
Rosén, A., Lekander, M., Jensen, K. B., Sachs, L., Petrović, P., Ingvar, M., & Enblom, A. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3925878 · Cited by 7
RetractedThe Placebo Effect Has Come of Age
Kirsch, I. (2011) · Cited by 2
Self-citationPlazebo- und Nozeboeffekte – Grundlagen, praktische und ethische Implikationen
Bingel, U. (2016) · Springer eBooks · doi:10.1007/978-3-662-49916-0_10 · Cited by 2
Дмитриевна, Т. О., Агибалова, Т. В., Shustov, D. I., Shustova, S. A., Buzik, O. Z., & Petrosyan, Y. E. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0576-6 · Cited by 3
A Kantian defence of placebo deception
Allen, A. (2019) · Bioethics News · doi:10.1007/s40592-019-00102-z · Cited by 2
It's Time to Listen to the Dummy What It Means When the Modest Placebo Speaks.
Alexander, W. (2017) · PubMed · Cited by 2
Caulley, L., James, J., & Hopkins, C. L. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.3723 · Cited by 3
Manufacturing the placebo effect
Hardman, D. I. (2022) · Philosophical Investigations · doi:10.1111/phin.12341 · Cited by 2
Placebo Effects and Functional Neurological Disorder: Helpful or Harmful?
Burke, M. J., & Lidstone, S. C. (2022) · Current clinical neurology · doi:10.1007/978-3-030-86495-8_27 · Cited by 3
Explaining and Solving Practical Problems Supernaturally
Watson‐Jones, R. E., & Legare, C. H. (2022) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190693350.013.7 · Cited by 4
Placeboeffekte in der Schmerzmedizin
Klinger, R., & Bingel, U. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57487-4_3 · Cited by 4
Placebo mechanisms for drug dose reduction: what is the evidence?
Enck, P., & Klosterhalfen, S. (2012) · Clinical Investigation · doi:10.4155/cli.12.109 · Cited by 2
Rapp, P. E., Cellucci, C. J., Darmon, D. M., & Keyser, D. O. (2022) · Psychiatry International · doi:10.3390/psychiatryint3020015 · Cited by 1
Harnessing the power of placebos and mitigating nocebo effects in clinical practice
Wettergreen, S. A., Plauche, A., & Stewart, M. P. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1692 · Cited by 2
“compared an open-label placebo to no treatment for patients with irritable bowel syndrome; and the results showed significant global improvement in the open-label group regarding symptom severity.(17) However, education with a standardized script framing the placebo substance to produce healing was an important elemen…”
ResultPlaceboeffekte in der Medizin: Ursachen, Mechanismen, Befunde
Meißner, K. (2022) · Chinesische Medizin / Chinese Medicine · doi:10.1007/s00052-022-00069-x · Cited by 2
“Diese sind nur zum Teil auf Placeboeffekte zurückzuführen; andere Ursachen für Verbesserungen in den Placebogruppen klinischer Studien sind der natürliche Krankheitsverlauf (z.B. spontane Verbesserungen der Symptomatik), Auswirkungen von Zusatzinterventionen sowie statistische Effekte, wie Regression zur Mitte.”
BackgroundPlacebo Use in Medicine: Use, Abuse & Therapy.
Khneizer, G. W., & Desai, R. (2022) · PubMed Central · Cited by 2
Non-Deceptive Placebos Can Promote Acts of Kindness: A Randomized Controlled Trial
Schienle, A., & Unger, I. (2023) · Behavioral Sciences · doi:10.3390/bs13090703 · Cited by 1
“However, non-deceptive placebo research has found that taking the placebo reliably is crucial, while positive expectations are helpful but not necessary [27,28].”
BackgroundColloca, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00182-3 · Cited by 3
An Overview of Complementary and Alternative Medicine
Casarin, A., Tangkiatkumjai, M., & Walker, D. (2017) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-2882-1.ch001 · Cited by 2
Barbis, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48566-1.00007-3 · Cited by 2
Kumaki, M., Takegawa, Y., & Hirata, K. (2018) · Journal of Information Processing · doi:10.2197/ipsjjip.26.285 · Cited by 2
Langewitz, W. A. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.00042-5 · Cited by 2
Visceral Pain: From Bench to Bedside
Elsenbruch, S., & Benson, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805408-6.00019-1 · Cited by 3
Evidence-based medicine, "placebos" and the homeopathy controversy
Turner, A. J. (2012) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 3
Placebo Studies (Double-Blind Studies)
Walach, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27050-5 · Cited by 2
Graz, B., Willcox, M. L., & Elisabetsky, E. (2015) · doi:10.1002/9781118930717.ch22 · Cited by 2
Kleine‐Borgmann, J., Schmidt, K., Hellmann, A., & Bingel, U. (2020) · Pain · doi:10.1097/j.pain.0000000000001804 · Cited by 3
Genes, Memes, Culture, and Psychosomatic Medicine: An Integrative Model
Leigh, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7119-6_3 · Cited by 1
Are placebos inert or powerful?Vice versa
Golomb, B. A. (2011) · Clinical Investigation · doi:10.4155/cli.11.142 · Cited by 1
Дмитриевна, Т. О., Агибалова, Т. В., Shustov, D. I., Shustova, S. A., Buzik, O. Z., & Petrosyan, Y. E. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611611261-68 · Cited by 2
Protection of Random Assignment
Powell, L. H., Kaufmann, P. G., & Freedland, K. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-39330-4_8 · Cited by 1
Kruse, J. J., Reynolds, C. D., Farag, A., & Anene, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823026-8.00025-0 · Cited by 1
de Leeuw, M., Laager, M., Gaab, J., Ruppen, W., & Schneider, T. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1238878 · Cited by 1
Baidwan, N. K., Tracy, T., Chiu, C.-Y., Nawshin, T., Hoenemeyer, T. W., Riser, E., Motl, R. W., Fontaine, K. R., & Mehta, T. S. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01674-w · Cited by 1
Mun, C. J., Contreras, E., Xiao, Y., Eckert, R., Harting, A., Damera, S., Perez, I., Pandey, H. K., Mardian, A. S., LoVecchio, F., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01692-8 · Cited by 1
“The video script is adapted from earlier OLP studies [29, 30].”
Frisaldi, E., Kleine‐Borgmann, J., Hartmann, H., Benson, S., Bingel, U., & Schmidt, K. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1529056 · Cited by 1
Placebo effects and emotion regulation: conceptual and neural similarities and differences
Bo, K., & Wager, T. D. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00004-2 · Cited by 1
Benedetti, F., & Shaibani, A. I. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00009-1 · Cited by 1
Alnasralla, M. B., & Nasralla, B. H. (2026) · Cureus · doi:10.7759/cureus.100612 · Cited by 4
“While methodological variability, individual differences, and ethical concerns pose challenges [27-37], open-label placebos offer an ethically acceptable approach to harness these effects [26,37].”
The role of expectations and tailored feedback on the open-label Placebo effect
Barnes, K., & Faasse, K. (2026) · Journal of Health Psychology · doi:10.1177/13591053251414005 · Cited by 1
“(Kaptchuk et al., 2010).”
The first on the dark side of the moon: Revisiting the first nonblind placebo trial
Gaab, J., Nascimento, A. F., Wehlage, C., & Park, L. C. (2026) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2026.112565 · Cited by 1
Evidentialism and Patient Testimony
Reverman, E. C. (2026) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhag004 · Cited by 2
Barbiani, D., Antonietti, A., & Pagnini, F. (2026) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2026.100673 · Cited by 1
“…memory through expectation-driven and affective mechanisms, which may operate similarly in both deceptive and open-label placebo effects (Benedetti et al., 2023; Charlesworth et al., 2017; Guevarra et al., 2020; Kaptchuk et al., 2010; Locher et al., 2017; Sezer et al., 2022; Spille et al., 2023).”
InfluentialLiedtke, C., Schaefer, M., & Enge, S. (2026) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2026.100361 · Cited by 1
“Sub-sequently, all participants received written instruction about the OLP rationale analogue to previous OLP trials [5,6].”
Zamfira, D. A., Fassina, T., Zaworski, K., Carlino, E., & Rossettini, G. (2026) · Experimental Physiology · doi:10.1113/ep093418 · Cited by 3
Placeboeffekte in der Schmerzmedizin
Klinger, R., & Bingel, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-37605-4_3 · Cited by 1
New Perspectives on the Placebo Effect: Implications for Research and Clinical Practice
Horowitz, S. (2012) · Alternative and Complementary Therapies · doi:10.1089/act.2012.18304 · Cited by 1
Der Depression die Stirn bieten – mit Botulinumtoxin
Wollmer, M. A., Krüger, T. H. C., & Kollewe, K. (2013) · Nervenheilkunde · doi:10.1055/s-0038-1633377 · Cited by 1
“Allerdings sind hohe Entblindungsraten bei Studien mit Psychopharmaka häufig und eine aktuelle Studie zeigt, dass Placeboeffekte nicht vollständig von der Qualität der Verblindung abhängig sind und auch Open-label-Placebobehandlungen eine klinische Verbesserung herbeiführen können (13, 16).”
BackgroundDepression in Clinical Practice
Rabbani, M. (1970) · Bangladesh Medical Journal · doi:10.3329/bmj.v40i1.9954 · Cited by 1
The Dawn of Clinical Medicine: Bronze Age Medical Practice in Egypt
Trevisanato, S. I., & Bioconsulting, S. (2011) · Cited by 2
Lobo, B. (2013) · TDX (Tesis Doctorals en Xarxa) · Cited by 1
Essay Suicide and the Drama of Self-consciousness 1
Hustvedt, S. (2013) · Cited by 5
Milgrom, L. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08939-3_12 · Cited by 1
Placeboeffekte bei chronischen Schmerzen: Forschungsstand und klinische Anwendung
Müller, M., & Bräscher, A. (2018) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-0043-121683 · Cited by 1
Fairchild, A. (2020) · Clinical Ethics · doi:10.1177/1477750920959556 · Cited by 1
“In a study of irritable bowel syndrome, compared to those receiving no treatment, the open-label placebo group had a greater reduction of symptoms.(39) However, in a study of depression the open-label placebo with rationale did not have any major difference from those without treatment.”
ResultBiološke osnove placebo-učinka
Šaravanja, N., & Ivanec, D. (2020) · Journal of Applied Health Sciences · doi:10.24141/1/6/2/10 · Cited by 1
Baseline reliability and early response in clinical trials of major depressive disorder
Targum, S. D. (2020) · Medical Research Archives · doi:10.18103/mra.v8i10.2241 · Cited by 2
“In fact, some authors argue that the mere participation in a clinical trial can generate a placebo response that can subsume a large part of the overall response (7-11).”
BackgroundSieg, M., Mark, E. B., Drewes, A. M., & Vase, L. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0115 · Cited by 1
García, O. L. I. (2018) · Recerca Revista de pensament i anàlisi · doi:10.6035/recerca.2018.22.2 · Cited by 1
A modern view of placebo and placebo-related effects
Benedetti, F. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198843177.003.0008 · Cited by 1
Intervening in the psychopath’s brain
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0007 · Cited by 1
The Stress, Healing, and Resilience Nursing Model of Whole Person Care
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_2 · Cited by 2
Complementary Medicine in the Classroom: Is it Science?
Trocco, F. (2023) · Current Issues in Education · doi:10.14507/cie.vol24iss1.2093 · Cited by 1
Kwon, A. H., Colloca, L., & Mackey, S. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2023.03.006 · Cited by 1
Placebo and Nocebo Effects: Biological and Cultural Aspects
Dodd, S., Forbes, M., & Berk, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_146-1 · Cited by 1
Placebo effects and research quality: What is good evidence?
Jonas, W. B., Goldman, D. A., Muhammed, S., Mullins, C. D., & Colloca, L. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197645444.003.0022 · Cited by 2
The Roles of Endogenous Opioids in Placebo and Nocebo Effects: From Pain to Performance to Prozac
Kerr, P. L., & Gregg, J. M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-45493-6_10 · Cited by 1
Placebo- und Noceboeffekte – Grundlagen, praktische und ethische Implikationen
Bingel, U. (2024) · Springer eBooks · doi:10.1007/978-3-662-69739-9_11 · Cited by 1
Mertens, M., & Clarke, A. J. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01874-1 · Cited by 2
Schienle, A., Wabnegger, A., & Tanzmeister, S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1645958 · Cited by 1
“For instance, in a highly cited OLP study by Kaptchuk et al. (18) on irritable bowel syndrome (IBS), 54% of patients in the OLP group were also taking IBS medication, and 24% were on antidepressants.”
Margaret McCartney: Honesty, placebos, and pain care
McCartney, M. (2015) · BMJ · doi:10.1136/bmj.h5103 · Cited by 2
Effectiveness of Selective Serotonin Reuptake Inhibitors for Irritable Bowel Syndrome.
Wilkins, T., Agabin, E., & Blake, L. (2015) · PubMed · Cited by 1
The Most Powerful Placebo Is Not a Pill
Nasrallah, H. A. (2011) · Current psychiatry · Cited by 1
Parsing placebo treatments: a response to Barnhill and Miller
Glackin, S. N. (2016) · Journal of Medical Ethics · doi:10.1136/medethics-2015-103082 · Cited by 1
Brook, M. G., & Fauver, R. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.1.131 · Cited by 3
Duloxetine for AI-associated joint pain in breast cancer patients
Tsuda, M., & Toi, M. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.03.28 · Cited by 1
Jaller, J. A., MacQuhae, F., & Nichols, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54825-0.00026-0 · Cited by 1
Treating psychiatric disorders: Less invasive and noninvasive interventions
Glannon, W. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780198758853.003.0004 · Cited by 1
Integral Yoga Psychology: Clinical Correlations
Miovic, M. (2018) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2018.37.1.199 · Cited by 1
Placebo trials without mechanisms: How far can they go?
Teira, D. (2019) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2019.101177 · Cited by 1
Consultation-Liaison Psychiatry and Psychosomatic Medicine: Where Do We Go from Here?
Leigh, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-12584-4_28 · Cited by 1
El‐Farargy, N. (2020) · Scottish Medical Journal · doi:10.1177/0036933019898816 · Cited by 1
“Remarkably, there is also limited evidence of improved patient outcomes even when participants know that the consumed substance is inert.(34,36,37) This demonstrates that even in the absence of ‘ethical deception’, healing occurs.”
BackgroundThe ethical dilemma of placebo use in clinical practice
Xu, C.-Y., & Yuan, C.-M. (2020) · Frontiers of Nursing · doi:10.2478/fon-2020-0033 · Cited by 1
Stuhlreyer, J., & Klinger, R. (2020) · Der Schmerzpatient · doi:10.1055/a-1205-5303 · Cited by 1
“[40] Kaptchuk TJ, Friedlander E, Kelley JM et al.”
BackgroundL'Aide-mémoire de psychologie médicale et de psychologie du soin
Bioy, A. (2012) · Dunod eBooks · doi:10.3917/dunod.bioy.2012.01.0063 · Cited by 1
Dealing With Placebo Effects: A Plea to Take Into Account Contextual Factors
Meynen, G., & Widdershoven, G. A. M. (2015) · The American Journal of Bioethics · doi:10.1080/15265161.2015.1074308 · Cited by 1
Metadata
- Authors
- Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- National Institutes of Health (US)
- University of Hull (GB)
- Corresponding author
- Kaptchuk, Ted J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-22
- Volume
- 5
- Issue
- 12
- Pages
- e15591
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3008733
- OpenAlex
- W2105330971
- Semantic Scholar
- 3d8aac4fba0e556c2d0898ad83cd3df11576e90c
- Cited by
- 900
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 48 · 2023: 56 · 2022: 55 · 2021: 67 · 2020: 72 · 2019: 55 · 2018: 97 · 2017: 48 · 2016: 55 · 2015: 55 · 2014: 65 · 2013: 48 · 2012: 58
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Health and Human Services
- Bernard Osher Foundation
- National Institutes of Health (5r01at000402-04)
- Japan Society for the Promotion of Science (13J11021)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (R01AT004662, K24AT004095, R01 AT00402-01)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- irritable bowel syndrome, placebo effect, open-label placebo, symptom severity, quality of life, patient-provider interaction, informed consent
- MeSH terms
- Adult, Female, Humans, Deception, Male, Middle Aged, Placebos, Time Factors, Treatment Outcome, Patient Satisfaction, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

